==Bristol-Myers (BMY) reported earnings on Thur 26 Oct 23 (b/o)

 

Bristol-Myers beats by $0.24, reports revs in-line; guides FY23 EPS above consensus

• Reports Q3 (Sep) earnings of $2.00 per share, excluding non-recurring items, $0.24 better than the FactSet Consensus of $1.76; revenues fell 2.2% year/year to $10.97 bln vs the $10.96 bln FactSet Consensus.
• Co raises guidance for FY23, sees EPS of $7.50 to $7.65 from $7.35 to $7.65, excluding non-recurring items, vs. $7.36 FactSet Consensus.
• FY23 revenue expected to be down in the low single digits.